scholarly journals Medication risk management and health equity in New Zealand general practice: a retrospective cross-sectional study

2021 ◽  
Vol 20 (1) ◽  
Author(s):  
Sharon Leitch ◽  
Jiaxu Zeng ◽  
Alesha Smith ◽  
Tim Stokes

Abstract Background Despite an overt commitment to equity, health inequities are evident throughout Aotearoa New Zealand. A general practice electronic alert system was developed to notify clinicians about their patient’s risk of harm due to their pre-existing medical conditions or current medication. We aimed to determine whether there were any disparities in clinician action taken on the alert based on patient ethnicity or other demographic factors. Methods Sixty-six New Zealand general practices from throughout New Zealand participated. Data were available for 1611 alerts detected for 1582 patients between 1 and 2018 and 1 July 2019. The primary outcome was whether action was taken following an alert or not. Logistic regression was used to assess if patients of one ethnicity group were more or less likely to have action taken. Potential confounders considered in the analyses include patient age, gender, ethnicity, socio-economic deprivation, number of long term diagnoses and number of long term medications. Results No evidence of a difference was found in the odds of having action taken amongst ethnicity groups, however the estimated odds for Māori and Pasifika patients were lower compared to the European group (Māori OR 0.88, 95 %CI 0.63–1.22; Pasifika OR 0.88, 95 %CI 0.52–1.49). Females had significantly lower odds of having action taken compared to males (OR 0.76, 95 %CI 0.59–0.96). Conclusions This analysis of data arising from a general practice electronic alert system in New Zealand found clinicians typically took action on those alerts. However, clinicians appear to take less action for women and Māori and Pasifika patients. Use of a targeted alert system has the potential to mitigate risk from medication-related harm. Recognising clinician biases may improve the equitability of health care provision.

2020 ◽  
Author(s):  
Sharon Leitch ◽  
Jiaxu Zeng ◽  
Alesha Smith ◽  
Tim Stokes

Abstract BackgroundDespite an overt commitment to equity, health inequities are evident throughout Aotearoa New Zealand. A general practice electronic alert system was developed to notify clinicians about their patient’s risk of harm due to their pre-existing medical conditions or current medication. We aimed to determine whether there were any disparities in clinician action taken on the alert based on patient ethnicity or other demographic factors.MethodsSixty-six New Zealand general practices from throughout New Zealand participated. Data were available for 1611 alerts detected for 1582 patients between 1 Jan 2018 and 1 July 2019. The primary outcome was whether action was taken following an alert or not. Logistic regression was used to assess if patients of one ethnicity group were more or less likely to have action taken. Potential confounders considered in the analyses include patient age, gender, ethnicity, socio-economic deprivation, number of long term diagnoses and number of long term medications.ResultsNo evidence of a difference was found in the odds of having action taken amongst ethnicity groups, however the estimated odds for Māori and Pasifika patients were lower compared to the European group (Māori OR 0.88, 95%CI 0.63–1.22; Pasifika OR 0.88, 95%CI 0.52–1.49). Females had significantly lower odds of having action taken compared to males (OR 0.76, 95%CI 0.59–0.96).ConclusionThis analysis of data arising from a general practice electronic alert system in New Zealand found clinicians typically took action on those alerts. However, clinicians appear to take less action for women and Māori and Pasifika patients. Use of a targeted alert system has the potential to mitigate risk from medication-related harm. Recognising clinician biases may improve the equitability of health care provision.


2015 ◽  
Vol 27 (3) ◽  
pp. 29-43 ◽  
Author(s):  
Polly Yeung ◽  
Lareen Cooper ◽  
Michael Dale

The purpose of this cross-sectional study was to investigate the prevalence and associated factors of elder abuse in a representative sample of older people in Aotearoa New Zealand. Analysis was conducted on responses from the second wave of the New Zealand Longitu- dinal Study of Ageing (NZLSA) omnibus survey of 3,923 adults aged 50-87 years. Using the elder mistreatment screening questions, the sample was split between those who identified of having experienced elder abuse (n = 529) and those who did not (n = 2417) from a large population-based study to compare on 19 variables (i.e. age, gender, marital status, living arrangement, education levels, ethnicity, personal income, total number of health conditions, physical health, mental health, ability to get around, economic wellbeing, loneliness, social and emotional loneliness, depression, happiness, satisfaction with life and quality of life). Significant differences were found on 16 of the variables assessed. Results suggested that those who have experienced elder abuse had a higher level of loneliness and poor economic wellbeing. They were more likely to experience depression, have poorer mental health and be less happy. The experience of abuse had significant impact on their satisfaction with life and overall quality of life. A better understanding of these risk factors associated with elder abuse in aging population will assist with both prevention and intervention. 


2019 ◽  
Vol 36 (5) ◽  
pp. 544-551 ◽  
Author(s):  
Ankie C M Hazen ◽  
Dorien L M Zwart ◽  
Judith M Poldervaart ◽  
Johan J de Gier ◽  
Niek J de Wit ◽  
...  

Abstract Objective To evaluate the process of clinical medication review for elderly patients with polypharmacy performed by non-dispensing pharmacists embedded in general practice. The aim was to identify the number and type of drug therapy problems and to assess how and to what extent drug therapy problems were actually solved. Method An observational cross-sectional study, conducted in nine general practices in the Netherlands between June 2014 and June 2015. On three pre-set dates, the non-dispensing pharmacists completed an online data form about the last 10 patients who completed all stages of clinical medication review. Outcomes were the type and number of drug therapy problems, the extent to which recommendations were implemented and the percentage of drug therapy problems that were eventually solved. Interventions were divided as either preventive (aimed at following prophylactic guidelines) or corrective (aimed at active patient problems). Results In total, 1292 drug therapy problems were identified among 270 patients, with a median of 5 (interquartile range 3) drug therapy problems per patient, mainly related to overtreatment (24%) and undertreatment (21%). The non-dispensing pharmacists most frequently recommended to stop medication (32%). Overall, 83% of the proposed recommendations were implemented; 57% were preventive, and 35% were corrective interventions (8% could not be assessed). Almost two-third (64%) of the corrective interventions actually solved the drug therapy problem. Conclusion Non-dispensing pharmacists integrated in general practice identified a large number of drug therapy problems and successfully implemented a proportionally high number of recommendations that solved the majority of drug therapy problems.


2017 ◽  
Vol 37 (1) ◽  
pp. 68-73 ◽  
Author(s):  
Hamish A Jamieson ◽  
Helen M Gibson ◽  
Rebecca Abey-Nesbit ◽  
Annabel Ahuriri-Driscoll ◽  
Sally Keeling ◽  
...  

2019 ◽  
Vol 11 (2) ◽  
pp. 159 ◽  
Author(s):  
Robert Haua ◽  
Jeff Harrison ◽  
Trudi Aspden

ABSTRACT IntroductionPharmacist integration into general practice is gaining momentum internationally, with benefits noted in reducing medication errors, improving chronic disease management and alleviating general practitioner workforce shortages. Little is known about how general practice pharmacists are working in New Zealand. AimThis study characterised the current landscape of pharmacist integration into general practice in New Zealand. MethodsAn online questionnaire was developed, piloted and distributed to all pharmacists in New Zealand. ResultsThirty-six responses were analysed. Respondents were more likely to be female, have been pharmacists for at least 10 years and all but one held formal postgraduate clinical pharmacy qualifications. Seven pharmacists were working as pharmacist prescribers. Primary health organisations (PHOs) were the most common employer, with funding primarily derived from either PHOs or District Health Boards. Pharmacist integration into general practice appears to have progressed further in particular regions of New Zealand, with most respondents located in the North Island. Tasks performed by respondents included medication reviews, managing long-term conditions and medicines reconciliation. Increased job satisfaction compared with previous roles was reported by most respondents. Funding and a general lack of awareness about pharmacists’ professional scope were seen as barriers to further expansion of the role. DiscussionThis study describes the characteristics of pharmacists currently working in general practices in New Zealand and provides insights into key requirements for the role. Understanding the way practice pharmacists are currently employed and funded can inform general practices considering employing pharmacists.


BJGP Open ◽  
2021 ◽  
pp. BJGPO.2020.0104
Author(s):  
Samantha Jane Beardsley ◽  
Isabel Dostal ◽  
James Cole ◽  
Ana Gutierrez ◽  
John Robson

BackgroundValproate is a known teratogen. In April 2018, the Medicines and Healthcare products Regulatory Agency (MHRA) restricted use in women and banned use in pregnancy, except for epilepsy with no other effective treatment. To date, there is limited information on valproate prescribing within primary care.AimTo characterise valproate prescribing to women of childbearing age, recorded advice or general practitioner prescribed contraception and recorded pregnancies.Design & settingA cross-sectional study of patients from all 141 general practices across three Clinical Commissioning Groups in East London.MethodWomen aged 15-44 years prescribed valproate between 1/10/2017-1/1/2020 were included. Exclusion criteria were early menopause, sterilisation procedures or hysterectomy. Pseudonymised data on valproate indication, pregnancy, pre-conception and contraception advice were retrospectively extracted from general practice consultation data. Data were analysed by quarter using univariate statistics.ResultsOf the total 1,042,463 registered patients, 344 women aged 15–44 years were prescribed valproate during the study period; 14 were excluded. There were 10 pregnancies during possible valproate exposure; one was terminated. During the study period, the number of women prescribed valproate significantly decreased (P=0.003). The pregnancy rate decreased from 9.9/1000 on valproate before the MHRA April 2018 warning, to an average of 2.8/1000 afterwards. Recorded pre-conception/contraception advice increased by 79%, from 24% to 43%, of women prescribed valproate.ConclusionWith continued pregnancies in women aged 15-44 years prescribed valproate, patient education and foetal outcomes remain ongoing concerns. Further improvements are needed to ensure women make informed reproductive choices and safeguard future pregnancies from valproate exposure.


BMJ Open ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. e047368
Author(s):  
Victoria Egli ◽  
Sandra Mandic ◽  
Tessa Pocock ◽  
Anantha Narayanan ◽  
Lisa Williams ◽  
...  

IntroductionNeighbourhood environments can have significant and enduring impacts on children’s physical, psychological and social health. Environments can impact health through promoting or hindering physical activity, active travel, and healthy eating in addition to opportunities for social interaction, cognitive development, rest and relaxation. There is a paucity of research that has examined neighbourhood and health priorities, strengths and needs from the perspectives of the community, and even less that has focused on the perspectives of children within communities. The aim of this article is to describe the research protocol for a project to gather child-identified needs and strengths-based solutions for promoting child health and well-being in urban neighbourhood environments.Methods and analysisThis participatory research project is designed to partner with children in school settings in Tāmaki Makaurau Auckland and Ōtepoti Dunedin, Aotearoa New Zealand. An abundant communities approach will be used with children to identify needs and strengths related to neighbourhoods and health. Specific methods including collaborative, creative, play-based methods such as concept-mapping activities and co-creation of final dissemination material on the key messages are described. Plans for researcher reflections, data analysis and dissemination are also detailed.Ethics and disseminationThis research has been approved by the University of Auckland Human Participants Ethics Committee. Results will be disseminated through child and researcher co-created output, a technical report and academic journal articles. By using evidence-based child-centred approaches to knowledge generation, we anticipate the research will generate new localised insights about children’s preferences and needs for healthy neighbourhoods which will be shared with stakeholders in planning and practice. The detailed session protocol including critical researcher reflections is shared in this manuscript for application, development and refinement in future research.


2016 ◽  
Vol 17 (1) ◽  
Author(s):  
Charlotte Weston ◽  
Alexander Gilkes ◽  
Stevo Durbaba ◽  
Peter Schofield ◽  
Patrick White ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document